Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Cash & Equivalents (2016 - 2025)

National Healthcare's Cash & Equivalents history spans 16 years, with the latest figure at $18.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 7.41% year-over-year to $18.1 million; the TTM value through Dec 2025 reached $18.1 million, down 7.41%, while the annual FY2025 figure was $18.1 million, 7.41% down from the prior year.
  • Cash & Equivalents reached $18.1 million in Q4 2025 per NHC's latest filing, down from $19.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $136.2 million in Q2 2024 to a low of $18.1 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $73.6 million, with a median of $77.1 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: surged 125.34% in 2023, then plummeted 86.67% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $107.6 million in 2021, then crashed by 45.48% to $58.7 million in 2022, then surged by 82.51% to $107.1 million in 2023, then tumbled by 81.73% to $19.6 million in 2024, then fell by 7.41% to $18.1 million in 2025.
  • Per Business Quant, the three most recent readings for NHC's Cash & Equivalents are $18.1 million (Q4 2025), $19.7 million (Q3 2025), and $18.2 million (Q2 2025).